The Economic Imperative for an AI Productivity Index in Healthcare: Beyond Clinical Promise to Fiscal Accountability.

A conceptual framework for measuring AI health equity

Artificial intelligence (AI) is increasingly embedded in health systems globally and has the potential to improve efficiency, diagnostic accuracy, and decision support. However, its benefits remain unevenly distributed, particularly in low- and middle-income countries (LMICs). Models developed using datasets from specific populations may perform poorly in other settings, reinforcing structural inequities rather than correcting them. This viewpoint proposes a composite framework, the AI in Healthcare Equity Index (AIHEI), to support measurable assessment of equity in health AI systems. The AIHEI is designed to assess equity across five domains: data representation, algorithmic fairness, transparency and explainability, governance and oversight, and community impact and benefit sharing. By generating a standardised score, the index could enable comparisons across technologies, incentivise improvement, and support regulation, procurement, publication, and funding decisions. Pilots across diverse health domains and geographic settings are needed to assess feasibility, refine domain weighting, and evaluate reliability, reproducibility, and validity. Important challenges include contextual definitions of fairness, data sovereignty, post-deployment monitoring, and the risk of metric gaming. Quantifying equity in health AI is essential to ensure that AI does not create, widen, or exacerbate existing disparities by neglecting underserved populations. A common, objective measure of AI-related health equity can help move the field from ethical aspiration toward measurable accountability, monitoring, and enforcement.

The Economic Impact of AI Adoption in Healthcare: Estimating National Cost Savings, Productivity Gains, and Long-Term Health Outcomes

It is argued that AI can generate substantial national value when deployed in high-volume, high-cost, and prevention-oriented services and offers policymakers a practical basis for prioritizing responsible AI investments that improve both healthcare efficiency and long-term patient outcomes.

Human-centered AI in healthcare teams: integrating clinical oversight, EHR auditability, and reimbursement pathways for responsible adoption

Background AI is being introduced into clinical workforces during a critical transition toward integrated, value-based models of care, where its greatest promise lies in augmenting clinician judgment and expanding the reach of already strained healthcare teams. Yet clinical adoption remains limited because most AI systems lack reimbursement pathways, impose substantial implementation costs, and lack standardized mechanisms for integration into electronic health records (EHRs). These gaps create misalignment between technological capability and clinical usability. This paper identifies financial, regulatory, and workflow structures required for AI to operate safely, predictably, and sustainably across key domains of healthcare. Methods This narrative synthesis reviews clinical, economic, regulatory, and implementation-science literature from 2022 to 2025. Four domains were analyzed: (1) AI augmentation of clinical workflows; (2) reimbursement structures and CPT coding pathways; (3) EHR-based AI deployment and governance; and (4) economic and equity considerations for large-scale implementation. Sources included peer-reviewed reviews, white papers, consensus statements, and health policy analyses. Results AI tools demonstrated benefits in diagnostic accuracy, decision support, and documentation efficiency, particularly in radiology, cardiology, and EHR-integrated workflows. Adoption was hindered by absent reimbursement for clinician-reviewed AI outputs. Implementation and monitoring costs fell heavily on health systems, risking widened disparities. Additional concerns included accuracy, bias, generalizability, and limited oversight. Enabling conditions included clinician-in-the-loop review, auditable outputs, equity-centered validation, and alignment with evolving payment models. Conclusions AI can strengthen healthcare teams and advance value-based care, but scaling requires aligned incentives, rigorous evaluation standards, equity safeguards, and coordinated governance—echoing lessons from national EHR implementation.

Medical Affairs in the Age of Complexity: From Scientific Support to Strategic Enterprise Integrator.

The AI-Driven Healthcare Value Framework—Rethinking Traditional Care Models in the Age of Automation

Highlights What are the main findings? This study introduces a comprehensive value framework tailored to artificial intelligence in healthcare, extending evaluation beyond narrow cost–outcome ratios. The framework highlights patient, provider, organizational, and system-level impacts as essential dimensions of healthcare value. It shows that conventional healthcare value models often fail to capture equity, trust, explainability, and environmental sustainability when AI and other digital tools are used at scale. The proposed model organizes these considerations into a structured framework that can be applied to AI-enabled healthcare settings. What are the implications of the main findings? The framework can help policymakers and health system leaders judge whether AI investments truly improve population health and reduce inequities. It provides researchers with clear dimensions for developing indicators and evaluation tools for responsible AI use in health services. It supports more people-centered, ethically grounded, and sustainable decision-making in healthcare innovation. It may also guide future implementation and assessment of AI systems in ways that balance effectiveness, fairness, and long-term system value. Abstract Background: The rapid adoption of artificial intelligence (AI) in healthcare and management information systems has posed both opportunities and challenges in assessing value across clinical, operational, governance and societal dimensions. Existing healthcare value models are inadequate for the dynamic, data-rich, and ethically complex nature of AI-enabled care and thus necessitate a broader evaluative framework. Objective: This paper proposes an AI-Augmented Healthcare Value Framework (AI-HVF) designed as a multidimensional evaluative lens for assessing value in AI-enabled healthcare across structural, process, outcome, cost, and governance domains. Methods: A narrative, theory-driven literature review was undertaken of healthcare quality frameworks, value-based healthcare, digital health, AI in medicine and public health to identify limitations of existing models and to derive the required dimensions for an updated framework. The dimensions were synthesized into an integrated conceptual model linking structures, processes, outcomes, costs and governance in AI-enabled healthcare. Results: AI-HVF transforms traditional healthcare value models in a data-rich and automated care era. Structural dimensions include digital infrastructure, workforce readiness, learning health systems, and operational efficiency; process dimensions include AI-supported clinical excellence, patient experience, prevention, and explainability; and outcome dimensions go beyond traditional clinical metrics to include equity, safety, continuity, provider well-being, sustainability, and societal value. It also includes real cost accounting and has governance, ethics and trust as an overarching layer that supports accountability, transparency and fairness across all domains. Conclusions: AI-HVF provides a multi-dimensional framework to assess, plan and govern AI in health care at the patient, organization, and system levels. It is intended to enable retrospective evaluation and prospective implementation. The framework offers a foundation for developing future indicators, pilot testing and for comparative evaluation of ethical, equitable and sustainable AI integration in healthcare.

A testable framework linking diagnostic AI contribution to outcome measurement in clinical decision support

Artificial intelligence-enabled clinical decision support systems (AI-CDSS) are increasingly embedded in diagnostic and therapeutic workflows, yet evaluation, procurement, and governance often remain anchored in model-centric indicators such as discrimination, calibration, sensitivity, and specificity. These indicators are necessary but insufficient for determining whether a deployed AI-CDSS improves patient-relevant outcomes, clinical workflow, resource use, economic performance, clinician and patient experience, learning, and equity. This article proposes a testable conceptual framework linking the Diagnostic AI Contribution Score (DACS) to outcome-domain prioritization and auditable measurement design. The contribution is theory-building and methodological rather than empirically validating: no new patient-level data were generated or analyzed. We conducted a concept-driven structured narrative synthesis across clinical AI evaluation, clinical decision support, health-services research, value-based care, software measurement, AI governance, and large language model (LLM) deployment. We used the synthesis to derive a DACS-informed framework for selecting outcome domains, specifying exposure–action–outcome linkage, and defining minimum telemetry needed for auditability. The revised framework provides four core outputs: (i) a six-domain taxonomy of outcome metrics for AI-CDSS, separating learning/governance from equity; (ii) a comparison with existing AI evaluation and reporting frameworks to clarify the framework’s incremental contribution; (iii) a DACS-to-domain mapping and explicitly illustrative prioritization heuristic, accompanied by a threshold-sensitivity logic; and (iv) a four-step measurement framework with minimum telemetry requirements and clinical implementation guardrails. LLM-specific extensions address provenance and version tracking, human mediation, documentation-quality audits, latency and compute metering, and workflow-mediated effects. We further specify clinical safety considerations including alert fatigue, override patterns by user group, automation bias and diagnostic anchoring, educational effects, de-implementation criteria, fallback workflows, integration with existing quality-management infrastructure, and patient-facing disclosure where appropriate. The proposed framework should be interpreted as a structured, hypothesis-generating model for proportional outcome measurement and governance. Future work should empirically test inter-rater reliability of DACS scoring, validate DACS-to-domain mappings through expert elicitation and prospective deployments, calibrate thresholds across use cases, and evaluate whether standardized telemetry improves attribution, monitoring, and accountability for AI-CDSS.